SenesTech, Inc. (SNES) Q1 2026 Earnings Call Transcript
SenesTech Inc (NASDAQ:SNES) Q1 EPS Beat Drives After-Hours Stock Surge Despite Revenue Miss
SenesTech Q1 2026 Earnings Call: Complete Transcript
SenesTech Q1 EPS $(0.39) Misses $(0.33) Estimate, Sales $493.000K Miss $632.000K Estimate
SenesTech shares are trading lower after the company reported worse-than-expected Q4 financial results.
SenesTech, Inc. (SNES) Q4 2025 Earnings Call Transcript
SenesTech Q4 EPS $(0.35) Misses $(0.30) Estimate, Sales $421.000K Miss $776.000K Estimate
SenesTech shares are trading higher after the company announced that its Evolve has been approved for use in New Zealand by the Ministry for Primary Industries.
SenesTech's Evolve® Approved in New Zealand
SenesTech Says Evolve Approved For Use In New Zealand By Ministry For Primary Industries
SenesTech Announces CEO Transition Plan
SenesTech President, CEO Joel Fruendt Intends To Retire, Effective June 30; Chair Jamie Bechtel Named Interim Executive Chair
SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control
SenesTech Adds Sarah Mann, Belize Raptor Center As Newest International Distributors Of Evolve Rat Birth Control
SenesTech Inc (SNES) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
SenesTech, Inc. (SNES) Q3 2025 Earnings Call Transcript
SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA
SenesTech shares are trading lower after the company reported mixed Q3 financial results.
SenesTech Q3 EPS $(0.28) Beats $(0.35) Estimate, Sales $690.000K Miss $730.000K Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.